HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Veronika Hartmann Selected Research

TGX 221

1/2021Topical Application of the PI3Kβ-Selective Small Molecule Inhibitor TGX-221 Is an Effective Treatment Option for Experimental Epidermolysis Bullosa Acquisita.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Veronika Hartmann Research Topics

Disease

2Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa)
01/2021 - 12/2020
2Skin Diseases (Skin Disease)
01/2021 - 12/2020

Drug/Important Bio-Agent (IBA)

1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2021
1TGX 221IBA
01/2021
1AutoantibodiesIBA
01/2021
1Collagen Type VIIIBA
01/2021
1Antigen-Antibody Complex (Immune Complex)IBA
12/2020
1Propranolol (Inderal)FDA LinkGeneric
12/2020